Farmas USA

Notas primeras presentaciones ASCO 2016 de LifeSci Capital
https://lifesci.bluematrix.com/sellside/EmailDocViewer?encrypt=92b3a667-b2f7-4732-a9c2-c75fa0328a63&mime=pdf&co=Lifesci&[email protected]&source=mail

Auguro un inicio de sesion movidito ...

NVAX

HZNP

Initiated at Buy at Goldman. PT $24

ONTY

Allá van! +13% y han llegado a +32% en PM (de momento sin un volumen descomunal...pero algo es algo)

Nada nuevo bajo el sol

https://www.sec.gov/Archives/edgar/data/1183765/000114420416106899/v441797_8k.htm

On June 2, 2016, Threshold Pharmaceuticals, Inc. (the Company) received preliminary comments from the U.S. Food and Drug Administration (FDA) relating to the Company’s request for a meeting indicating that the Company’s analysis of the data from the randomized Phase III study, EMR200592-001 (N=693), conducted under a Special Protocol Agreement with the FDA, and the data from the supporting randomized Phase II study, TH-CR-404 (N=214),would not provide adequate efficacy data to support the submission of a New Drug Application (“NDA”) for evofosfamide for the treatment of patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma previously untreated with chemotherapy.

THLD

futuros verdes , premarkets verdes ...

A ver si duran todo el día! A las 18:30 último speech de Yellen antes de que se tome una decisión oficial la semana que viene sobre los tipos (u otras medidas necesarias). El dato del empleo de la semana pasada hizo mucho daño...

http://es.investing.com/news/economy-news/yellen,-presidenta-de-la-fed,-habla-hoy-del-alza-de-tipos-y-del-empleo-328503

me he decidido por la pasta y colocado mas ventas en apertura ... ya veremos que pasa ...

NVAX

ONTY

ongoing "Triplet" Phase 1b trial and the future ONT-380 product development plan will be presented at the Company's R&D Day on June 14th in New York City

A ver si sigue subiendo...